Hyperbilirubinemia. Physiological jaundice (intense)(prolonged) NOS
Conditions
Interventions
Administration of 5mg of zinc sulfate BD/per day in the treatment group.
Treatment - Drugs
Administration of 5mg of zinc sulfate BD/per day in the treatment group
Sponsors
Vice- Chancellor for Research Technology Affairs, Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Days to 28 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: Full term newborns; with of age for more than 72 hours & serum bilirubin level more than 15 mg/dl. Exclusion criteria: All babies who received medication such as zinc sulphate & phenobarbital by mothers or newborn
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum bilirubin's level. Timepoint: Total serum bilirubin level at the time of admission, daily during the hospitalization and at the time of the discharge. Method of measurement: Measuring of the total serum bilirubin level by biochemistry kits manufactured in Iran and by the method of spectrophotometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum zinc's level. Timepoint: At the time of admission and discharge. Method of measurement: Auto analyser. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Bahram Ranjbar
Amirkola Children’s Hospital
Outcome results
None listed